The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetcall Regulatory News (NET)

Share Price Information for Netcall (NET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 88.50
Bid: 88.00
Ask: 89.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.136%)
Open: 88.50
High: 88.50
Low: 88.50
Prev. Close: 88.50
NET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

One in five NHS Trusts use AMC

10 Apr 2013 07:00

RNS Number : 9639B
Netcall PLC
10 April 2013
 



 

10 April 2013

NETCALL PLC

("Netcall", the "Company" or the "Group")

 

Netcall's Appointment Management Cycle now helping one in five NHS Acute Trusts and Health Boards save millions

 

Netcall plc (AIM: NET), a leading customer engagement software provider, is pleased to announce that following two recent contract wins, one in five of the NHS Acute Trusts and Health Boards in the UK are now implementing applications from Netcall's award winning Appointment Management Cycle (AMC) designed to combat "Did not attend" (DNA) rates and manage appointment systems in the healthcare market.

 

AMC was the first combined application suite to be launched following Netcall's acquisition of Telephonetics in July 2010 and this has recently been augmented with additional business process automation modules from Netcall's Eden solution set.

 

The pressure on the NHS continues to grow as it seeks ways to deliver £20bn of efficiency savings over four years to bridge the gap between flat funding and rising demand. This is against a backdrop of rising patient expectations and call for better services. Patient communication is expected to be one of the top three areas of future NHS IT spend according to a recent report from EH Insider.

 

High DNA rates, caused by the public not attending their appointments, are a major drain on healthcare resources and are believed to cost the NHS in the region of £700m a year. Netcall's Appointment Management Cycle suite has been designed specifically to empower Trusts to 'Remind, Rebook and Refill' appointments efficiently. AMC innovatively and cost effectively deals with missed appointments across hospitals and outpatient departments, leading to less cancellations and re-scheduling of appointments; resulting in an enhanced patient experience and significant reduction in associated costs.

 

The flexibility of the AMC suite will allow Trusts to expand the applications they use as the benefits of improved patient communication and appointment management are realised.

 

The judging panel of Building Better Healthcare Awards, 2012, headed by Roy Lilley, NHS Commentator, commented, "Appointment Management Cycle seems a simple solution, but it really makes a difference to the patient experience and to the number of missed appointments, saving the health service a lot of money."

 

Henrik Bang, CEO of Netcall, commented, "The growing number of implementations of Netcall's Appointment Management Cycle (AMC) is helping NHS Acute Trusts and Health Boards to significantly reduce their 'Did Not Attend' (DNA) rates, creating substantial costs savings for the organisations. The AMC solution set has been developed by focusing on our NHS customers' needs, and includes a variety of communication channels which enables Trusts and Health Boards to tailor communication to all age groups, including the younger generation who are considered the biggest offenders of missing appointments. We are delighted with the rapid success we have had in the uptake of our AMC solution set which Netcall continues to enhance, and we are currently in discussion with a number of NHS Acute Trusts about implementing AMC within their organisations."

 

 

For further enquiries, please contact:

 

Netcall plc

Tel. +44 (0) 330 333 6100

Henrik Bang, CEO

Michael Jackson, Chairman

James Ormondroyd, Group Finance Director

finnCap Limited (Nominated Adviser and Broker)

Tel. +44 (0) 20 7220 0500

Stuart Andrews, Corporate Finance

Victoria Bates / Simon Johnson, Corporate Broking

Newgate Threadneedle

Tel. +44 (0) 20 7653 9850

Caroline Evans-Jones / Hilary Millar/ Heather Armstrong

 

 

 

About Netcall plc

Netcall is a UK company quoted on the AIM market of the London Stock Exchange. Netcall's software product suite provides compelling business process solutions for end-to-end customer engagement, incorporating intelligent contact handling, workforce optimisation, business process management and enterprise content management. Our target markets comprise organisations of all sizes, including many blue-chip companies with global contact centre operations. The Netcall software platform helps organisations meet the growing demands of their customers and prospects whilst improving internal efficiencies, thereby increasing profitability and customer satisfaction.

 

Netcall's customer base contains nearly 750 organisations in both the private and public sectors. These include over 70%of the NHS Acute Health Trusts and Boards, major telecoms operators such as BT and Cable & Wireless and leading organisations including Interflora, Lloyds TSB, Cineworld, Interserve, Orange, Prudential and Thames Water.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUKUBROVASRAR
Date   Source Headline
30th Apr 20242:07 pmRNSExercise of Options and Total Voting Rights
22nd Apr 20247:00 amRNSNetcall launches Liberty Converse CX
16th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSExercise of Options, Director/PDMR Dealing and TVR
28th Mar 20247:58 amRNSExercise of Options and Total Voting Rights
20th Mar 20249:07 amRNS£7.6m Liberty platform Contract Renewal
6th Mar 20247:00 amRNSHalf-year Report
31st Jan 20242:05 pmRNSHolding(s) in Company
26th Jan 20243:39 pmRNSExercise of Options and Total Voting Rights
24th Jan 20242:14 pmRNSExercise of Options, PDMR Dealing & TVR
23rd Jan 20247:01 amRNSAcquisition of Skore Labs Limited
23rd Jan 20247:00 amRNSTrading Update and Notice of Results
19th Dec 202312:00 pmRNSResult of AGM
19th Dec 20237:00 amRNSAGM Statement
15th Dec 20235:31 pmRNSExercise of Options and Total Voting Rights
5th Dec 20233:53 pmRNSHolding(s) in Company
29th Nov 20233:11 pmRNSExercise of Options and Total Voting Rights
20th Nov 20234:00 pmRNSNotice of AGM and Posting of Annual Report
20th Nov 20237:00 amRNSBoard Succession & Directorate Change
11th Oct 20237:00 amRNSFinal Results for the Year Ended 30 June 2023
29th Sep 20237:00 amRNSNotice of Results and Presentations
25th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20234:44 pmRNSHolding(s) in Company
18th Aug 20239:15 amRNSExercise of Options and Total Voting Rights
20th Jul 20237:00 amRNSTrading Update and Contract Renewal
30th May 20234:49 pmRNSHolding(s) in Company
15th May 20234:10 pmRNSHolding(s) in Company
4th Apr 20234:30 pmRNSExercise of Options and Total Voting Rights
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
8th Mar 20237:01 amRNSHalf-year Report
8th Mar 20237:00 amRNSAppointment of Joint Broker
27th Jan 20231:20 pmRNSHolding(s) in Company
24th Jan 20234:30 pmRNSExercise of Options, Director/PDMR Dealing and TVR
24th Jan 20237:00 amRNSTrading Update and Notice of Results
16th Jan 20235:35 pmRNSHolding(s) in Company
16th Jan 20235:00 pmRNSExtension of LTIP for Senior Management
20th Dec 20229:45 amRNSHolding(s) in Company
13th Dec 20226:22 pmRNSExercise of Options, Director/PDMR Dealing and TVR
8th Dec 202212:30 pmRNSResult of AGM
8th Dec 20227:00 amRNSAGM Statement
6th Dec 20225:05 pmRNSHolding(s) in Company
29th Nov 20227:00 amRNSExercise of Options and Total Voting Rights
25th Nov 20224:00 pmRNSExercise of Options and Total Voting Rights
10th Nov 20227:00 amRNSNotice of AGM and Directorate Change
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Oct 20222:00 pmRNSFinal redemption of BGF loan note
6th Oct 20222:00 pmRNSHolding(s) in Company
6th Oct 202210:30 amRNSHolding(s) in Company
5th Oct 20224:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.